A highly potent nanobody-based bispecific therapeutic provides broad-spectrum protection against ebolavirus

Journal:

Nature Communications

Published:

2026-03-17

DOI:

10.1038/s41467-026-70464-6

Affiliations:

10

Authors:

23

Go to article

Institutions	Authors	Share
Center for Biosafety Mega-Science, WIV CAS, China	10.500000 10.500000	0.46
State Key Laboratory of Immune Response and Immunotherapy, China	4.533333	0.20
Anhui Genebiol Biotech, China	2.333333	0.10
University of Science and Technology of China (USTC), China	2.166667	0.09
Division of Life Sciences and Medicine, USTC, China	1.533333	0.07
Changchun Veterinary Research Institute, CAAS, China	1.000000	0.04
The First Affiliated Hospital, USTC, China	0.533333	0.02
Institute of Health and Medicine, Hefei Comprehensive National Science Center, China	0.400000	0.02

Interested in Medical Microbiology?